Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain × Analgesics, Opioid × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Supratentorial Neoplasms 1 Postoperative Cognitive Complications 1 Pain, Postoperative 1 Pain 1 Lung Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

Fentanyl 7 Acetaminophen 5 Zoledronic Acid 4 Oxycodone 4 Ketamine 4 Bupivacaine 4 Sufentanil 3 Hydromorphone 3 Diclofenac 3 Ropivacaine 2 Pregabalin 2 Ketorolac 2 Ibuprofen 2 Ibandronic Acid 2 Esketamine 2 Epinephrine 2 naloxegol 1 chloroprocaine 1 acetaminophen, aspirin, caffeine drug combination 1 Varenicline 1 Uterine Artery Embolization 1 Ultracet 1 Therapeutics 1 Propofol 1 Pamidronate 1 Naproxen 1 Morphine 1 Midazolam 1 Methadone 1 Mepivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02359175 2023-06-27

SEAVATS

Odense University Hospital

Phase 4 Completed

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡